Taking people in NetherlandsPhase 1
Imaging how brentuximab spreads in the body in CD30-positive lymphoma
Tests a radioactive tracer version of brentuximab in adults with high-risk diffuse large B-cell lymphoma.
Plain-language title generated from the registry record
Registry title: Takeda Brentuximab; Molecular Imaging of Zirconium-89-labeled Brentuximab as a Tool to Investigate brentuximab biodistribution in CD30-positive Lymphoma
Key facts
- Where
- Groningen, NetherlandsSee the site
- Phase
- Phase 1
Where in Netherlands
- Universitair Medisch Centrum GroningenGroningen, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitair Medisch Centrum Groningen
- Trial code
- EU 2024-511151-18-01
- Record updated
- 25 November 2024